92 related articles for article (PubMed ID: 1465475)
1. Comparison of sorbinil and ponalrestat (Statil) diminution of proteinuria in the BB rat.
Beyer-Mears A; Murray FT; Cruz E; Rountree J; Sciadini M
Pharmacology; 1992; 45(5):285-91. PubMed ID: 1465475
[TBL] [Abstract][Full Text] [Related]
2. Reversal of proteinuria by sorbinil, an aldose reductase inhibitor in spontaneously diabetic (BB) rats.
Beyer-Mears A; Murray FT; Del Val M; Cruz E; Sciadini M
Pharmacology; 1988; 36(2):112-20. PubMed ID: 3127836
[TBL] [Abstract][Full Text] [Related]
3. Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Edelist T; Varagiannis E
Pharmacology; 1986; 32(1):52-60. PubMed ID: 3080763
[TBL] [Abstract][Full Text] [Related]
4. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
[TBL] [Abstract][Full Text] [Related]
5. The polyol pathway, sorbinil, and renal dysfunction.
Beyer-Mears A
Metabolism; 1986 Apr; 35(4 Suppl 1):46-54. PubMed ID: 3083209
[TBL] [Abstract][Full Text] [Related]
6. Proteinuria associated with hypertension and diabetes mellitus.
Beyer-Mears A; Del Val M; Cruz E; Murray FT
Pharmacology; 1988; 36(3):188-97. PubMed ID: 3368505
[TBL] [Abstract][Full Text] [Related]
7. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
Beyer-Mears A; Mistry K; Diecke FP; Cruz E
Pharmacology; 1996 May; 52(5):292-302. PubMed ID: 8807673
[TBL] [Abstract][Full Text] [Related]
8. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy.
Ranganathan S; Krempf M; Feraille E; Charbonnel B
Diabete Metab; 1993; 19(2):257-61. PubMed ID: 8339858
[TBL] [Abstract][Full Text] [Related]
9. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
10. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
Mauer SM; Steffes MW; Azar S; Brown DM
Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.
Sima AA; Prashar A; Zhang WX; Chakrabarti S; Greene DA
J Clin Invest; 1990 May; 85(5):1410-20. PubMed ID: 2110189
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
Pugliese G; Tilton RG; Speedy A; Oates PJ; Williamson JR
Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
[TBL] [Abstract][Full Text] [Related]
13. Impaired induction of nerve ornithine decarboxylase activity in the streptozotocin-diabetic rat is prevented by the aldose reductase inhibitor ponalrestat.
Pekiner C; McLean WG
Br J Pharmacol; 1990 Dec; 101(4):978-80. PubMed ID: 2128196
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase inhibition by ponalrestat (statil) does not prevent proteinuria in long-term diabetic rats.
Reddi AS; Jyothirmayi GN
J Diabetes Complications; 1993; 7(4):233-40. PubMed ID: 8219366
[TBL] [Abstract][Full Text] [Related]
15. Effect of aldose reductase inhibition and insulin treatment on retinal capillary basement membrane thickening in BB rats.
Chakrabarti S; Sima AA
Diabetes; 1989 Sep; 38(9):1181-6. PubMed ID: 2504638
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural observations on myelinated fibres in experimental diabetes: effect of the aldose reductase inhibitor ponalrestat given alone or in conjunction with insulin therapy.
Bhoyrul S; Sharma AK; Stribling D; Mirrlees DD; Peterson RG; Farber MO; Thomas PK
J Neurol Sci; 1988 Jun; 85(2):131-47. PubMed ID: 2968441
[TBL] [Abstract][Full Text] [Related]
17. Dissociation between biochemical and functional effects of the aldose reductase inhibitor, ponalrestat, on peripheral nerve in diabetic rats.
Cameron NE; Cotter MA
Br J Pharmacol; 1992 Dec; 107(4):939-44. PubMed ID: 1467842
[TBL] [Abstract][Full Text] [Related]
18. The effect of aldose reductase inhibition and dietary protein restriction on renal function in experimental diabetes mellitus.
McCormack AJ; Hak LJ; Finn WF
Ren Fail; 1991; 13(4):267-74. PubMed ID: 1780495
[TBL] [Abstract][Full Text] [Related]
19. The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat.
Kamijo M; Cherian PV; Sima AA
Diabetologia; 1993 Oct; 36(10):893-8. PubMed ID: 8243866
[TBL] [Abstract][Full Text] [Related]
20. Recent clinical experience with aldose reductase inhibitors.
Krans HM
J Diabetes Complications; 1992; 6(1):39-44. PubMed ID: 1562757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
